Watson Beats Auxilium's Testim Patent Suit In Court Trial

Law360, Los Angeles (December 17, 2014, 7:35 PM EST) -- A New Jersey federal judge on Tuesday invalidated a patent related to Auxilium Pharmaceuticals Inc.'s Testim testosterone gel for men, saying that the patent fails for obviousness, derivation and improper inventorship, following a bench trial over Watson Laboratories Inc.'s attempt to create a generic version.

The decision hands a victory in the case to Watson, now Actavis Inc., after Auxilium agreed to "streamline" the case. Auxilium initially asserted 10 patents, but ultimately agreed to focus on only a single claim in Patent No. 7,608,607, according to court documents.

U.S. District Judge Jose L. Linares filed the order on Tuesday but sealed...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!